Skip to content

Category: Top Stories

Walmart-owned Sam’s Club raises its annual membership fee to $60

Business Men Break Sit Read Newspaper

Sam’s Club is hiking membership fees as its annual sales and membership grow and as high gas prices call attention to one of its key perks.

This JPMorgan income ETF was named one of the best by Morningstar. Where its manager is investing now

Business Men Break Sit Read Newspaper

JPMorgan’s Sam Witherow explains why the JPMorgan Dividend Leaders ETF is outperforming and where he sees opportunities for income.

These charts offer hints on what’s next for market volatility after a stormy March

Business Men Break Sit Read Newspaper

Following a tumultuous month, traders are seeking signs that the market’s character has flipped back to positive.

Wall Street loses patience with Nike as turnaround drags, China weakness deepens

Business Men Break Sit Read Newspaper

Nike warned that its turnaround is taking longer than it expected, leading three Wall Street banks to downgrade the stock as investors lose patience.

Eli Lilly opposes push to pass Trump’s drug pricing deals into law, CEO says

Business Men Break Sit Read Newspaper

Eli Lilly opposes the White House’s push to codify “most favored nation” drug pricing into law, CEO Dave Ricks said in an interview with CNBC.

Buy these small-cap stocks set for big gains in the spring, says Oppenheimer

Business Men Break Sit Read Newspaper

The small-cap Russell 2000 ended March with losses of more than 5%, but the firm has spotted a few names that could see a surge.

Franklin Templeton acquires digital assets investment firm in active crypto management push

Business Men Break Sit Read Newspaper

Franklin Templeton has agreed to buy 250 Digital, which will join the newly established unit Franklin Crypto, as the firm deepens its digital assets push.

Stocks making the biggest moves midday: Eli Lilly, Hasbro, Philip Morris, Intel, Micron & more

Business Men Break Sit Read Newspaper

These are the stocks posting the largest moves in midday trading.

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

Business Men Break Sit Read Newspaper

The FDA approval of Eli Lilly’s GLP-1 pill Foundayo comes nearly three months after Novo Nordisk’s oral version of Wegovy hit the market.

SpaceX confidentially files for IPO, setting stage for record offering

Business Men Break Sit Read Newspaper

Elon Musk’s SpaceX is reportedly targeting a valuation of around $1.75 trillion in its forthcoming IPO.

← Previous
Next →

Ready to take your stock trading to the next level? Sign up now to receive exclusive market analyses, insightful tips, and valuable resources straight to your inbox. Don’t miss out on the opportunity to stay ahead in the ever-evolving world of trading!

JOIN OUR COMMUNITY

Join our growing community of educated investors working together to build wealth with a diversified outlook at investment opportunities

Copyright © 2023. All Rights Reserved.

  • Privacy & Policy
  • Disclaimer